The high affinity IgE receptor (FcεRI) expression and function in airway smooth muscle

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2013, Pages 86-94

  Redhu, Naresh Singh ^a   Gounni, Abdelilah S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Airway inflammation; Airway remodeling; Fc epsilon receptor; IgE; Passive sensitization; TSLP

Indexed keywords

ALLERGEN; CALCIUM ION; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; GRANULOCYTE CHEMOTACTIC PROTEIN 2; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE SYK; RANTES; STAT3 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY REMODELING; AIRWAY SMOOTH MUSCLE; ALLERGIC ASTHMA; ANTIGEN BINDING; ARTICLE; AUTOCRINE EFFECT; BINDING SITE; BREATHING MUSCLE; CALCIUM CELL LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MAST CELL; MUSCLE GROWTH; NATURAL KILLER CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER;

AIRWAY REMODELING; ANIMALS; ASTHMA; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, IGE;

EID: 84873142090     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.04.004     Document Type: Article

References (145)

1. Chapman K.R. Asthma in Canada: missing the treatment targets. CMAJ 2008, 178:1027-1028.
2. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008, 31:143-178.
3. Busse W.W., Lemanske R.F. Asthma. N Engl J Med 2001, 344:350-362.
4. Holgate S.T. The epidemic of allergy and asthma. Nature 1999, 402:B2-B4.
5. Murphy D.M., O'Byrne P.M. Recent advances in the pathophysiology of asthma. Chest 2010, 137:1417-1426.
6. O'Byrne P.M., Hargreave F.E., Kirby J.G. Airway inflammation and hyperresponsiveness. Am Rev Respir Dis 1987, 136:S35-S37.
7. Hamid Q., Tulic M.K., Liu M.C., Moqbel R. Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol 2003, 111:S5-S12. discussion S-7.
8. Hamid Q., Tulic M. Immunobiology of asthma. Annu Rev Physiol 2009, 71:489-507.
9. Halayko A.J., Amrani Y. Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 2003, 137:209-222.
10. Panettieri R.A. Airway smooth muscle: immunomodulatory cells that modulate airway remodeling?. Respir Physiol Neurobiol 2003, 137:277-293.
11. Hershenson M.B., Brown M., Camoretti-Mercado B., Solway J. Airway smooth muscle in asthma. Annu Rev Pathol 2008, 3:523-555.
12. Damera G., Panettieri R.A. Does airway smooth muscle express an inflammatory phenotype in asthma?. Br J Pharmacol 2011, 163:68-80.
13. Hakonarson H., Grunstein M.M. Autocrine regulation of airway smooth muscle responsiveness. Respir Physiol Neurobiol 2003, 137:263-276.
14. Gounni A.S. The high-affinity IgE receptor (FcepsilonRI): a critical regulator of airway smooth muscle cells?. Am J Physiol Lung Cell Mol Physiol 2006, 291:L312-L321.
15. Johansson S.G., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F., et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol 2004, 113:832-836.
16. Aas K. The biochemical and immunological basis of bronchial asthma 1972, Charles C Thomas, Springfield (IL).
17. Gould H.J., Sutton B.J. IgE in allergy and asthma today. Nat Rev Immunol 2008, 8:205-217.
18. Gould H.J., Sutton B.J., Beavil A.J., Beavil R.L., McCloskey N., Coker H.A., et al. The biology of IGE and the basis of allergic disease. Annu Rev Immunol 2003, 21:579-628.
19. Poulsen L.K., Hummelshoj L. Triggers of IgE class switching and allergy development. Ann Med 2007, 39:440-456.
20. Dreskin S.C., Goldsmith P.K., Strober W., Zech L.A., Gallin J.I. Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels. J Clin Invest 1987, 79:1764-1772.
21. Smurthwaite L., Durham S.R. Local IgE synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep 2002, 2:231-238.
22. Kinet J.P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 1999, 17:931-972.
23. Gordon J.R., Galli S.J. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 1991, 174:103-107.
24. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6:135-142.
25. Bonnefoy J.Y., Lecoanet-Henchoz S., Gauchat J.F., Graber P., Aubry J.P., Jeannin P., et al. Structure and functions of CD23. Int Rev Immunol 1997, 16:113-128.
26. Delespesse G., Sarfati M., Wu C.Y., Fournier S., Letellier M. The low-affinity receptor for IgE. Immunol Rev 1992, 125:77-97.
27. Acharya M., Borland G., Edkins A.L., Maclellan L.M., Matheson J., Ozanne B.W., et al. CD23/FcepsilonRII: molecular multi-tasking. Clin Exp Immunol 2010, 162:12-23.
28. Kinet J.P., Blank U., Ra C., White K., Metzger H., Kochan J. Isolation and characterization of cDNAs coding for the beta subunit of the high-affinity receptor for immunoglobulin E. Proc Natl Acad Sci U S A 1988, 85:6483-6487.
29. Dombrowicz D., Lin S., Flamand V., Brini A.T., Koller B.H., Kinet J.P. Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity 1998, 8:517-529.
30. Donnadieu E., Jouvin M.H., Kinet J.P. A second amplifier function for the allergy-associated Fc(epsilon)RI-beta subunit. Immunity 2000, 12:515-523.
31. Siraganian R.P., de Castro R.O., Barbu E.A., Zhang J. Mast cell signaling: the role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants. FEBS Lett 2010, 584:4933-4940.
32. Gounni A.S., Lamkhioued B., Koussih L., Ra C., Renzi P.M., Hamid Q. Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma. FASEB J 2001, 15:940-949.
33. Gounni A.S., Lamkhioued B., Delaporte E., Dubost A., Kinet J.P., Capron A., et al. The high-affinity IgE receptor on eosinophils: from allergy to parasites or from parasites to allergy?. J Allergy Clin Immunol 1994, 94:1214-1216.
34. Smith S.J., Ying S., Meng Q., Sullivan M.H., Barkans J., Kon O.M., et al. Blood eosinophils from atopic donors express messenger RNA for the alpha, beta, and gamma subunits of the high-affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein. J Allergy Clin Immunol 2000, 105:309-317.
35. Novak N., Kraft S., Bieber T. IgE receptors. Curr Opin Immunol 2001, 13:721-726.
36. Novak N., Kraft S., Bieber T. Unraveling the mission of FcepsilonRI on antigen-presenting cells. J Allergy Clin Immunol 2003, 111:38-44.
37. Barnes P.J. Novel signal transduction modulators for the treatment of airway diseases. Pharmacol Ther 2006, 109:238-245.
38. Denyer J., Patel V. Syk kinase inhibitors in allergic diseases. Drug News Perspect 2009, 22:146-150.
39. Siraganian R.P. Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol 2003, 15:639-646.
40. Shiue L., Zoller M.J., Brugge J.S. Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE. J Biol Chem 1995, 270:10498-10502.
41. Zhang J., Billingsley M.L., Kincaid R.L., Siraganian R.P. Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J Biol Chem 2000, 275:35442-35447.
42. Parravicini V., Gadina M., Kovarova M., Odom S., Gonzalez-Espinosa C., Furumoto Y., et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 2002, 3:741-748.
43. Jabril-Cuenod B., Zhang C., Scharenberg A.M., Paolini R., Numerof R., Beaven M.A., et al. Syk-dependent phosphorylation of Shc. A potential link between FcepsilonRI and the Ras/mitogen-activated protein kinase signaling pathway through SOS and Grb2. J Biol Chem 1996, 271:16268-16272.
44. Song J.S., Gomez J., Stancato L.F., Rivera J. Association of a p95 Vav-containing signaling complex with the FcepsilonRI gamma chain in the RBL-2H3 mast cell line. Evidence for a constitutive in vivo association of Vav with Grb2, Raf-1, and ERK2 in an active complex. J Biol Chem 1996, 271:26962-26970.
45. Graham T.E., Pfeiffer J.R., Lee R.J., Kusewitt D.F., Martinez A.M., Foutz T., et al. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling. J Immunol 1998, 161:6733-6744.
46. Prausnitz C., Kustner H. Studies in hypersensitivity. Chem Abs 1921, 15:3676.
47. Levy D.A., Osler A.G. Studies on the mechanisms of hypersensitivity phenomena. XV. Enhancement of passive sensitization of human leukocytes by heparin. J Immunol 1967, 99:1062-1067.
48. Dunlop L.S., Smith A.P., Piper P.J. The effect of histamine antagonists on antigen-induced contractions of sensitized human bronchus in vitro [proceedings]. Br J Pharmacol 1977, 59:475P.
49. Antonissen L.A., Mitchell R.W., Kroeger E.A., Kepron W., Tse K.S., Stephens N.L. Mechanical alterations of airway smooth muscle in a canine asthmatic model. J Appl Physiol 1979, 46:681-687.
50. Rabe K.F. Mechanisms of immune sensitization of human bronchus. Am J Respir Crit Care Med 1998, 158:S161-S170.
51. Mitchell R.W., Rabe K.F., Magnussen H., Leff A.R. Passive sensitization of human airways induces myogenic contractile responses in vitro. J Appl Physiol 1997, 83:1276-1281.
52. Mitchell R.W., Ruhlmann E., Magnussen H., Leff A.R., Rabe K.F. Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity. Am J Physiol 1994, 267:L218-L222.
53. Schmidt D., Rabe K.F. Immune mechanisms of smooth muscle hyperreactivity in asthma. J Allergy Clin Immunol 2000, 105:673-682.
54. Peat J.K., Toelle B.G., Dermand J., van den Berg R., Britton W.J., Woolcock A.J. Serum IgE levels, atopy, and asthma in young adults: results from a longitudinal cohort study. Allergy 1996, 51:804-810.
55. Souhrada M., Souhrada J.F. Immunologically induced alterations of airway smooth muscle cell membrane. Science 1984, 225:723-725.
56. Rabe K.F., Watson N., Dent G., Morton B.E., Wagner K., Magnussen H., et al. Inhibition of human airway sensitization by a novel monoclonal anti-IgE antibody, 17-9. Am J Respir Crit Care Med 1998, 157:1429-1435.
57. Hakonarson H., Carter C., Kim C., Grunstein M.M. Altered expression and action of the low-affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle. The Journal of allergy and clinical immunology 1999, 104:575-584.
58. Hakonarson H., Grunstein M.M. Autologously up-regulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. Proc Natl Acad Sci U S A 1998, 95:5257-5262.
59. Grunstein M.M., Hakonarson H., Hodinka R.L., Maskeri N., Kim C., Chuang S. Mechanism of cooperative effects of rhinovirus and atopic sensitization on airway responsiveness. Am J Physiol Lung Cell Mol Physiol 2001, 280:L229-L238.
60. Grunstein M.M., Hakonarson H., Leiter J., Chen M., Whelan R., Grunstein J.S., et al. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002, 282:L520-L528.
61. Hakonarson H., Maskeri N., Carter C., Chuang S., Grunstein M.M. Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J Clin Invest 1999, 104:657-667.
62. Belleau J.T., Gandhi R.K., McPherson H.M., Lew D.B. Research upregulation of CD23 (FcepsilonRII) expression in human airway smooth muscle cells (huASMC) in response to IL-4, GM-CSF, and IL-4/GM-CSF. Clin Mol Allergy 2005, 3:6.
63. Gounni A.S., Wellemans V., Yang J., Bellesort F., Kassiri K., Gangloff S., et al. Human airway smooth muscle cells express the high affinity receptor for IgE (Fc epsilon RI): a critical role of Fc epsilon RI in human airway smooth muscle cell function. J Immunol 2005, 175:2613-2621.
64. Sayers I., Helm B.A. The structural basis of human IgE-Fc receptor interactions. Clin Exp Allergy 1999, 29:585-594.
65. Balzar S., Strand M., Rhodes D., Wenzel S.E. IgE expression pattern in lung: relation to systemic IgE and asthma phenotypes. J Allergy Clin Immunol 2007, 119:855-862.
66. Galli S.J., Tsai M., Piliponsky A.M. The development of allergic inflammation. Nature 2008, 454:445-454.
67. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002, 346:1699-1705.
68. Margulis A., Nocka K.H., Brennan A.M., Deng B., Fleming M., Goldman S.J., et al. Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels: influence of cytokines, matrix metalloproteases, and serine proteases. J Immunol 2009, 183:1739-1750.
69. Montagnac G., Yu L.C., Bevilacqua C., Heyman M., Conrad D.H., Perdue M.H., et al. Differential role for CD23 splice forms in apical to basolateral transcytosis of IgE/allergen complexes. Traffic 2005, 6:230-242.
70. Li H., Nowak-Wegrzyn A., Charlop-Powers Z., Shreffler W., Chehade M., Thomas S., et al. Transcytosis of IgE-antigen complexes by CD23a in human intestinal epithelial cells and its role in food allergy. Gastroenterology 2006, 131:47-58.
71. Heijink I.H., van Oosterhout A., Kapus A. Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. Eur Respir J 2010, 36:1016-1026.
72. Berger P., Walls A.F., Marthan R., Tunon-de-Lara J.M. Immunoglobulin E-induced passive sensitization of human airways: an immunohistochemical study. Am J Respir Crit Care Med 1998, 157:610-616.
73. Xia Y.C., Schuliga M., Shepherd M., Powell M., Harris T., Langenbach S.Y., et al. Functional expression of IgG-Fc receptors in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2011, 44:665-672.
74. Redhu N.S., Saleh A., Shan L., Gerthoffer W.T., Kung S.K., Halayko A.J., et al. Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FcepsilonRI) and IgE-dependant activation of human airway smooth muscle cells. PLoS One 2009, 4. e6153.
75. Roth M., Tamm M. The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells. Ann Allergy Asthma Immunol 2010, 104:152-160.
76. Redhu N.S., Saleh A., Lee H.C., Halayko A.J., Ziegler S.F., Gounni A.S. IgE induces transcriptional regulation of thymic stromal lymphopoietin in human airway smooth muscle cells. J Allergy Clin Immunol 2011, 128:892-896. e2.
77. Wang L., Turner W.C., Hussaini S.H., Chitano P., Murphy T.M. Effects of IgE and IL-4 on gene expression in proliferative and contractile human airway smooth muscle cells. Am J Respir Crit Care Med 2010, 181. A2121.
78. Mazlyzam A.L., Aminuddin B.S., Saim L., Ruszymah B.H. Human serum is an advantageous supplement for human dermal fibroblast expansion: clinical implications for tissue engineering of skin. Archives of medical research 2008, 39:743-752.
79. Tateishi K., Ando W., Higuchi C., Hart D.A., Hashimoto J., Nakata K., et al. Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications. Cell Transplantation 2008, 17:549-557.
80. Redhu N.S., Shan L., Gounni A.S. Fc{varepsilon} receptor expression in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2012, 46:559-560.
81. Marone G., Spadaro G., Palumbo C., Condorelli G. The anti-IgE/anti-FcepsilonRIalpha autoantibody network in allergic and autoimmune diseases. Clin Exp Allergy 1999, 29:17-27.
82. Nawata Y., Koike T., Yanagisawa T., Iwamoto I., Itaya T., Yoshida S., et al. Anti-IgE autoantibody in patients with bronchial asthma. Clin Exp Immunol 1984, 58:348-356.
83. Rudolf M.P., Furukawa K., Miescher S., Vogel M., Kricek F., Stadler B.M. Effect of anti-IgE antibodies on Fc epsilonRI-bound IgE. J Immunol 1996, 157:5646-5652.
84. Sun R.S., Chen X.H., Sui J.F., Liu R.Q., Cheng T.M., Ran X.Z., et al. Detecting anti-FcepsilonRI autoantibodies in patients with asthma by flow cytometry. J Int Med Res 2008, 36:1214-1219.
85. Hide M., Barr R.M., Francis D.M., Greaves M.W. IgE receptor autoantibodies. Autoantibodies 1996, 423-429. Elsevier Science B V, The Netherlands. J.B. Peter, Y. Shoenfeld (Eds.).
86. Hide M., Francis D.M., Grattan C.E., Hakimi J., Kochan J.P., Greaves M.W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599-1604.
87. Pachlopnik J.M., Horn M.P., Fux M., Dahinden M., Mandallaz M., Schneeberger D., et al. Natural anti-FcepsilonRIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 2004, 22:43-51.
88. Vassella C.C., de Weck A.L., Stadler B.M. Natural anti-IgE auto-antibodies interfere with diagnostic IgE determination. Clin Exp Allergy 1990, 20:295-303.
89. McClain D.A., Maegawa H., Lee J., Dull T.J., Ulrich A., Olefsky J.M. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem 1987, 262:14663-14671.
90. Olson J.K., Grose C. Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J Virol 1997, 71:4042-4054.
91. Wang J., Cheng X., Xiang M.X., Alanne-Kinnunen M., Wang J.A., Chen H., et al. IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice. J Clin Invest 2011, 121:3564-3577.
92. Kraft S., Kinet J.P. New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol 2007, 7:365-378.
93. Alphonse M.P., Saffar A.S., Shan L., HayGlass K.T., Simons F.E., Gounni A.S. Regulation of the high affinity IgE receptor (Fc epsilonRI) in human neutrophils: role of seasonal allergen exposure and Th-2 cytokines. PLoS One 2008, 3. e1921.
94. Lantz C.S., Yamaguchi M., Oettgen H.C., Katona I.M., Miyajima I., Kinet J.P., et al. IgE regulates mouse basophil Fc epsilon RI expression in vivo. J Immunol 1997, 158:2517-2521.
95. Novak N., Tepel C., Koch S., Brix K., Bieber T., Kraft S. Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors. J Clin Invest 2003, 111:1047-1056.
96. Yamaguchi M., Lantz C.S., Oettgen H.C., Katona I.M., Fleming T., Miyajima I., et al. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997, 185:663-672.
97. Yano K., Yamaguchi M., de Mora F., Lantz C.S., Butterfield J.H., Costa J.J., et al. Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability. Lab Invest 1997, 77:185-193.
98. Lee J.H., Kaminski N., Dolganov G., Grunig G., Koth L., Solomon C., et al. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol 2001, 25:474-485.
99. Hasegawa M., Nishiyama C., Nishiyama M., Akizawa Y., Takahashi K., Ito T., et al. Regulation of the human Fc epsilon RI alpha-chain distal promoter. J Immunol 2003, 170:3732-3738.
100. Donnadieu E., Jouvin M.H., Rana S., Moffatt M.F., Mockford E.H., Cookson W.O., et al. Competing functions encoded in the allergy-associated F(c)epsilonRIbeta gene. Immunity 2003, 18:665-674.
101. Roth M. Is there a regulatory role of immunoglobulins on tissue forming cells relevant in chronic inflammatory lung diseases?. J Allergy (Cairo) 2011, 2011:721517.
102. Roth M., Tamm M. Airway smooth muscle cells respond directly to inhaled environmental factors. Swiss Med Wkly 2010, 140. w13066.
103. Zhou B., Comeau M.R., De Smedt T., Liggitt H.D., Dahl M.E., Lewis D.B., et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005, 6:1047-1053.
104. Al-Shami A., Spolski R., Kelly J., Keane-Myers A., Leonard W.J. A role for TSLP in the development of inflammation in an asthma model. J Exp Med 2005, 202:829-839.
105. Ying S., O'Connor B., Ratoff J., Meng Q., Fang C., Cousins D., et al. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 2008, 181:2790-2798.
106. Ying S., O'Connor B., Ratoff J., Meng Q., Mallett K., Cousins D., et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005, 174:8183-8190.
107. Ito T., Wang Y.H., Duramad O., Hori T., Delespesse G.J., Watanabe N., et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005, 202:1213-1223.
108. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002, 3:673-680.
109. Gilliet M., Soumelis V., Watanabe N., Hanabuchi S., Antonenko S., de Waal-Malefyt R., et al. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 2003, 197:1059-1063.
110. Tliba O., Panettieri R.A. Noncontractile functions of airway smooth muscle cells in asthma. Annu Rev Physiol 2009, 71:509-535.
111. Zhang K., Shan L., Rahman M.S., Unruh H., Halayko A.J., Gounni A.S. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2007, 293:L375-L382.
112. Redhu N.S., Saleh A., Halayko A.J., Ali A.S., Gounni A.S. Essential role of NF-kappaB and AP-1 transcription factors in TNF-alpha-induced TSLP expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2011, 300:L479-L485.
113. Redhu N.S., Gounni A.S. Function and mechanisms of TSLP/TSLPR complex in asthma and COPD. Clin Exp Allergy 2011.
114. Kaur D., Doe C., Woodman L., Wan H., Sutcliffe A., Hollins F., et al. Mast cell-airway smooth muscle crosstalk: the role of thymic stromal lymphopoietin. Chest 2011.
115. Shan L., Redhu N.S., Saleh A., Halayko A.J., Chakir J., Gounni A.S. Thymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways. J Immunol 2010, 184:7134-7143.
116. Smelter D.F., Sathish V., Thompson M.A., Pabelick C.M., Vassallo R., Prakash Y.S. Thymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscle. J Immunol 2010, 185:3035-3040.
117. Liu Y.J. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol 2007, 120:45-46. 238-44; quiz.
118. Burgess J.K., Carlin S., Pack R.A., Arndt G.M., Au W.W., Johnson P.R., et al. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?. J Allergy Clin Immunol 2004, 113:683-689.
119. Lazaar A.L., Albelda S.M., Pilewski J.M., Brennan B., Pure E., Panettieri R.A. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J Exp Med 1994, 180:807-816.
120. Lazaar A.L., Amrani Y., Hsu J., Panettieri R.A., Fanslow W.C., Albelda S.M., et al. CD40-mediated signal transduction in human airway smooth muscle. J Immunol 1998, 161:3120-3127.
121. Lazaar A.L., Reitz H.E., Panettieri R.A., Peters S.P., Pure E. Antigen receptor-stimulated peripheral blood and bronchoalveolar lavage-derived T cells induce MHC class II and ICAM-1 expression on human airway smooth muscle. Am J Respir Cell Mol Biol 1997, 16:38-45.
122. Rabe K.F., Calhoun W.J., Smith N., Jimenez P. Can anti-IgE therapy prevent airway remodeling in allergic asthma?. Allergy 2011, 66:1142-1151.
123. Camoretti-Mercado B. Targeting the airway smooth muscle for asthma treatment. Transl Res 2009, 154:165-174.
124. Roth M., Johnson P.R., Borger P., Bihl M.P., Rudiger J.J., King G.G., et al. Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 2004, 351:560-574.
125. Naureckas E.T., Ndukwu I.M., Halayko A.J., Maxwell C., Hershenson M.B., Solway J. Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle. Am J Respir Crit Care Med 1999, 160:2062-2066.
126. Wilson D.R., Merrett T.G., Varga E.M., Smurthwaite L., Gould H.J., Kemp M., et al. Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics. Am J Respir Crit Care Med 2002, 165:22-26.
127. Kalesnikoff J., Huber M., Lam V., Damen J.E., Zhang J., Siraganian R.P., et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001, 14:801-811.
128. Katoh N., Kraft S., Wessendorf J.H., Bieber T. The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes. J Clin Invest 2000, 105:183-190.
129. Kashiwakura J., Otani I.M., Kawakami T. Monomeric IgE and mast cell development, survival and function. Adv Exp Med Biol 2011, 716:29-46.
130. Saffar A.S., Alphonse M.P., Shan L., Hayglass K.T., Simons F.E., Gounni A.S. IgE modulates neutrophil survival in asthma: role of mitochondrial pathway. J Immunol 2007, 178:2535-2541.
131. Kang J.Y., Kim J.W., Kim J.S., Kim S.J., Lee S.H., Kwon S.S., et al. Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murine model of chronic asthma. J Asthma 2010, 47:374-380.
132. Siraganian R.P., Zhang J., Suzuki K., Sada K. Protein tyrosine kinase Syk in mast cell signaling. Mol Immunol 2002, 38:1229-1233.
133. Gounni A.S., Wellemans V., Yang J., Bellesort F., Kassiri K., Gangloff S., et al. Human airway smooth muscle cells express the high affinity receptor for IgE (Fc{epsilon}RI): a critical role of Fc{epsilon}RI in human airway smooth muscle cell function. J Immunol 2005, 175:2613-2621.
134. Amrani Y., Panettieri R.A. Modulation of calcium homeostasis as a mechanism for altering smooth muscle responsiveness in asthma. Curr Opin Allergy Clin Immunol 2002, 2:39-45.
135. Hamawy M.M., Mergenhagen S.E., Siraganian R.P. Protein tyrosine phosphorylation as a mechanism of signalling in mast cells and basophils. Cell Signal 1995, 7:535-544.
136. Amrani Y., Panettieri R.A. Airway smooth muscle: contraction and beyond. Int J Biochem Cell Biol 2003, 35:272-276.
137. Ammit A.J., Armour C.L., Black J.L. Smooth-muscle myosin light-chain kinase content is increased in human sensitized airways. Am J Respir Crit Care Med 2000, 161:257-263.
138. Ma X., Cheng Z., Kong H., Wang Y., Unruh H., Stephens N.L., et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am J Physiol Lung Cell Mol Physiol 2002, 283:L1181-L1189.
139. Jiang H., Rao K., Halayko A.J., Liu X., Stephens N.L. Ragweed sensitization-induced increase of myosin light chain kinase content in canine airway smooth muscle. Am J Respir Cell Mol Biol 1992, 7:567-573.
140. Kawakami T., Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J Immunol 2005, 175:4167-4173.
141. Zhang J., Berenstein E.H., Evans R.L., Siraganian R.P. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med 1996, 184:71-79.
142. van der Kleij H., Charles N., Karimi K., Mao Y.K., Foster J., Janssen L., et al. Evidence for neuronal expression of functional Fc (epsilon and gamma) receptors. J Allergy Clin Immunol 2010, 125:757-760.
143. Ganguly S., Grodzki C., Sugden D., Moller M., Odom S., Gaildrat P., et al. Neural Adrenergic/Cyclic AMP regulation of the immunoglobulin E receptor {alpha}-Subunit expression in the Mammalian pinealocyte: a neuroendocrine/immune response link?. J Biol Chem 2007, 282:32758-32764.
144. Untersmayr E., Bises G., Starkl P., Bevins C.L., Scheiner O., Boltz-Nitulescu G., et al. The high affinity IgE receptor Fc epsilonRI is expressed by human intestinal epithelial cells. PLoS One 2010, 5. e9023.
145. Campbell A.M., Vachier I., Chanez P., Vignola A.M., Lebel B., Kochan J., et al. Expression of the high-affinity receptor for IgE on bronchial epithelial cells of asthmatics. Am J Respir Cell Mol Biol 1998, 19:92-97.